A news service out of Mumbai, India is reporting about DyAnsys Inc’s ANSiscope, a portable device designed to test for autonomic dysfunction in diabetics. Diabetic autonomic neuropathy is a common condition, in which the autonomic nervous system–a system that regulates all the major physiologic processes from sweating to blood pressure control–is out of whack. The device is based on a proprietary algorithm that performs the calculation of percentage of autonomic dysfunction. It is not the first device to be based on data extrapolation from an algorithm. For example, Philips’s Bispectral Index analyser (BIS® monitor) is an example of the FDA-approved algorithm-based device that monitors the level of anesthesia/awareness in an anesthetized patient.
DyAnsys Inc. is a Burlingame, CA-based company. To read more about ANSiscope, go to the company’s website.